Showing results (61-70 of 210) with videos related to
Sort By:
Pageof 21
Diabetes Research and Clinical Practice|April 25, 2007
Impact of mitochondrial ROS production on diabetic vascular complicationsTakeshi Nishikawa, Daisuke Kukidome, Kazuhiro Sonoda, et al.Diabetes Research and Clinical Practice|May 8, 2007
Impact of mitochondrial ROS production in the pathogenesis of insulin resistanceTakeshi Nishikawa, Daisuke Kukidome, Kazuhiro Sonoda, et al.International Journal of Molecular Sciences|November 9, 2019
Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin CombinationShizuya Yamashita, Hidenori Arai, Koutaro Yokote, et al.Nihon Jinzo Gakkai Shi|April 30, 2005
[Clinical courses of two male siblings on hemodialysis for Fabry disease ]Kazuko Itoh, Motoko Tanaka, Kazutaka Matsushita, et al.Journal of Diabetes Investigation|March 29, 2017
Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001-2010: Report of the Committee on Causes of Death in Diabetes MellitusJiro Nakamura, Hideki Kamiya, Masakazu Haneda, et al.Internal Medicine (Tokyo, Japan)|October 6, 2012
Rapid amelioration of hyperglycemia facilitated by dasatinib in a chronic myeloid leukemia patient with type 2 diabetes mellitusKeiko Ono, Hitoshi Suzushima, Yuko Watanabe, et al.Atherosclerosis|April 11, 2016
Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trialShun Ishibashi, Shizuya Yamashita, Hidenori Arai, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|December 22, 2009
A novel combination of mild electrical stimulation and hyperthermia: general concepts and applicationsHirofumi Kai, Mary Ann Suico, Saori Morino, et al.Diabetes Research and Clinical Practice|January 28, 2006
A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapyAkiko Matsuyoshi, Seiya Shimoda, Kaku Tsuruzoe, et al.Journal of Diabetes Investigation|July 25, 2020
Rapid and dramatic glucose-lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinomaMotoyuki Igata, Yoshitaka Yagi, Satoko Hanatani, et al.Pageof 21